ZTS (ZTS) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NYSE

Key Metrics

• Price: $129.79
• Market Cap: $56.83B
• P/E Ratio: 21.38
• EPS: $6.03
• Dividend Yield: 0.02%
• 52-Week High: $174.45
• 52-Week Low: $114.76

Market Sentiment

ZTS currently has a Bullish sentiment score of 0.28.

About ZTS

Zoetis Inc. (ZTS) is a leading global animal health company dedicated to improving the health and well-being of livestock and companion animals. As the largest manufacturer of medicines and vaccines for animals, Zoetis leverages advanced research and development to offer a comprehensive range of innovative products that enhance productivity in animal agriculture and support the well-being of pets globally. Committed to sustainability and animal welfare, Zoetis is well-positioned to meet the i...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for ZTS and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

What is ZTS's current dividend yield?

ZTS (ZTS) has a current dividend yield of 0.02%.

Does ZTS pay dividends?

Yes, ZTS pays dividends with a current yield of 0.02%.

What is ZTS's P/E ratio?

ZTS has a price-to-earnings (P/E) ratio of 21.38.

What is ZTS's market cap?

ZTS (ZTS) has a market capitalization of $56.83B with a current stock price of $129.79.